# \[e-drug\] UNITAID RFP: hepatitis C medicines and diagnostics in HIV/HCV co-infection

**URL:** <https://talk.edrugplus.org/t/e-drug-unitaid-rfp-hepatitis-c-medicines-and-diagnostics-in-hiv-hcv-co-infection/38525>\
**Category:** e-drug\
**Created:** [February 11, 2013, 2:37pm UTC](https://talk.edrugplus.org/t/e-drug-unitaid-rfp-hepatitis-c-medicines-and-diagnostics-in-hiv-hcv-co-infection/38525 "2013-02-11T14:37:45Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Fabienne\_MAERTENS](https://avatars.discourse-cdn.com/v4/letter/f/58f4c7/32.png) [@Fabienne\_MAERTENS](https://talk.edrugplus.org/u/Fabienne_MAERTENS)\
**Post date:** [February 11, 2013, 2:37pm UTC](https://talk.edrugplus.org/t/e-drug-unitaid-rfp-hepatitis-c-medicines-and-diagnostics-in-hiv-hcv-co-infection/38525/1 "2013-02-11T14:37:45Z")

</div>

E-DRUG: UNITAID RFP: hepatitis C medicines and diagnostics in HIV/HCV co-infection  
----------------------------------------------------------------------------

UNITAID Invitation to bid - ITB 2013.06 "Services to provide an overview of  
issues, challenges and opportunities with regard to hepatitis C medicines  
and diagnostics in the context of HIV/HCV co-infection"

UNITAID is a global health initiative, established to provide sustainable,  
predictable and additional funding to significantly impact on market  
dynamics to reduce prices and increase the availability and supply of high  
quality medicines, diagnostics and related commodities for the treatment of  
HIV/AIDS, malaria and tuberculosis, primarily for populations in low-income  
and lower-middle income countries.

UNITAID provides funding support to programmatic partners across three  
disease areas (HIV/AIDS, tuberculosis and malaria) to address gaps in the  
provision of quality medicines, diagnostics and other health commodities  
through market-based approaches and interventions. We have a need for  
suitably qualified bidders for a UNITAID project to provide "an overview of  
issues, challenges and opportunities with regard to hepatitis C medicines  
and diagnostics in the context of HIV/HCV co-infection".

A description of the requirements is provided in the following website:  
[http://bit.ly/WTunam](http://bit.ly/WTunam). If you are interested in being considered for this  
work, please respond no later than 22 February 2013, COB, to  
laryeal@who.int\<mailto:laryeal@who.int\>.

Deadline date: 22 February 2013 at 17:00

Link to the ITB website/documents: [http://bit.ly/WTunam](http://bit.ly/WTunam)

Link to UNITAID Website: [http://www.unitaid.eu/](http://www.unitaid.eu/)

regards

Fabienne MAERTENS  
Assistant (Team) - Market Dynamics  
UNITAID  
Geneva  
Switzerland  
Tel +41 22 791 1546  
maertensf@unitaid.who.int  
www.unitaid.eu